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Bcl9 and Pygopus (Pygo) are obligateWnt/β-catenin cofactors inDrosophila, yet their contribution toWnt signaling
during vertebrate development remains unresolved. Combining zebrafish and mouse genetics, we document a
conserved, β-catenin-associated function for BCL9 and Pygo proteins during vertebrate heart development.
Disrupting the β-catenin–BCL9–Pygo complex results in a broadly maintained canonical Wnt response yet perturbs
heart development and proper expression of key cardiac regulators. Our work highlights BCL9 and Pygo as selective
β-catenin cofactors in a subset of canonical Wnt responses during vertebrate development. Moreover, our results
implicate alterations in BCL9 and BCL9L in human congenital heart defects.
[Keywords: CRISPR–Cas9; cardiovascular development; congenital heart disease; heart; transcription;
Wnt signaling]
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The secreted factors of the Wnt family provide key mor-
phogen activities during vertebrate development and tis-
sue homeostasis (Nusse and Clevers 2017). Binding of
the Wnt ligand to the transmembrane receptors of the
Frizzled family and their LRP5/6 coreceptors triggers cy-
toplasmic events that culminate in stabilizing β-catenin
that thenmoves into the nucleus to act as a transcription-
al regulator (Nusse and Clevers 2017). Nuclear β-catenin
orchestrates canonical Wnt target gene expression by re-
cruiting a host of cofactors to Wnt-responsive elements
(WREs) occupied by TCF/LEF transcription factors (Mosi-
mann et al. 2009). In Drosophila, the coupling of the his-
tone code reader and plant homology domain (PHD)
finger protein Pygopus (Pygo) via the adaptor protein Leg-
less (Lgs) to the β-catenin N-terminal Armadillo repeats is
necessary for virtually all canonical Wnt signaling-depen-
dent responses (Kramps et al. 2002; Townsley et al. 2004a;
van Tienen et al. 2017). Lgs was shown to simultaneously
bind Pygo and β-catenin via two evolutionarily conserved
domains: the homology domain 1 (HD1) and HD2
(Kramps et al. 2002; Townsley et al. 2004b). InDrosophila,
the protein complex TCF/LEF> β-catenin >Lgs >Pygo,
termed “chain of adaptors,” is required to efficiently acti-
vate Wnt target gene expression (Städeli and Basler 2005).
In support of their role in Drosophila, recent biochemical
evidence further suggested that Pygo–BCL9 act as con-
necting factors of chromatin-engaged complexes for the
assembly of a Wnt-specific enhanceosome (van Tienen
et al. 2017).
Vertebrate genomes commonly harbor two paralogs of
lgs (Bcl9 and Bcl9l [Bcl9/9l]), and two of pygo (Pygo1 and
Pygo2 [Pygo1/2]). Morpholino antisense experiments and
overexpression studies have suggested functions in β-
catenin-associated axis formation during gastrulation inPresent addresses: 6Department of Clinical and Experimental Medicine
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cine (WCMM); Linköping University, S-58185 Linköping, Sweden; 7Inter-
national Centre for Genetic Engineering and Biotechnology (ICGEB)
Trieste, Molecular Medicine Group, 34149 Trieste, Italy.
8These authors contributed equally to this work.
Corresponding authors: christian.mosimann@imls.uzh.ch, kb@imls.uzh.ch
Article published online ahead of print. Article and publication date are
online at http://www.genesdev.org/cgi/doi/10.1101/gad.315531.118.
© 2018 Cantù et al. This article is distributed exclusively by Cold Spring
Harbor Laboratory Press for the first six months after the full-issue publi-
cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After
six months, it is available under a Creative Commons License (Attribu-
tion-NonCommercial 4.0 International), as described at http://creative-
commons.org/licenses/by-nc/4.0/.
GENES & DEVELOPMENT 32:1443–1458 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/18; www.genesdev.org 1443
 Cold Spring Harbor Laboratory Press on November 20, 2018 - Published by genesdev.cshlp.orgDownloaded from 
Xenopus and zebrafish (Brembeck et al. 2004; Kennedy
et al. 2010). Nonetheless, genetic loss of function in mice
has questioned their relevance for canonicalWnt signaling
in mammals: The deletion of Bcl9/9l or Pygo1/2 did not
cause a general abrogation of canonical Wnt signaling in
mouse development (Li et al. 2007; Song et al. 2007; Cantù
et al. 2013, 2014). Mouse mutant analysis has further em-
phasized that BCL9 and Pygo proteins have evolved β-
catenin-independent functions in mammals, including
the genetic interaction with Pax6 during eye lens forma-
tion, a role in chromatin compaction during spermatogen-
esis, and cytoplasmic activity in enamel formation during
tooth development (Song et al. 2007; Cantù et al. 2013,
2014, 2017). Whether and to what extent BCL9/9L and
Pygo1/2 contribute at all to β-catenin-dependent processes
during mammalian development remain to be resolved.
Here, we provide genetic and molecular evidence that
vertebrate BCL9 and Pygo proteins contribute as tissue-
specific mediators of β-catenin in the development of
specific structures and organs, in particular during heart
formation. In zebrafish mutants for the bcl9 and pygo
genes or upon selective chemical inhibition of the BCL9–
β-catenin interaction, we uncovered that disrupting the
β-catenin–BCL9–Pygo complex causes limited develop-
mental phenotypes, including heart defects. In mice,
both constitutive and heart-specific conditional loss of
Bcl9/9l or Pygo1/2 or the simultaneous impairment of
the BCL9/9L–β-catenin and BCL9/9L–PYGO2 interac-
tions leads to heart malformations, which include defects
in chamber septation and outflow tract (OFT) and valve
formation. These data reveal that, in vertebrates, the
Wnt-dependent function of the BCL9–Pygo module is re-
stricted to select processes. Transcriptome analyses estab-
lished that, in the developing heart and pharyngeal
structures, the β-catenin–BCL9–Pygo complex regulates
the expression of tissue-specific groups of genes. In addi-
tion, genome-wide chromatin-binding profiling revealed
that β-catenin and PYGO co-occupy putative cis-regulato-
ry regions of cardiac regulatory factors. Collectively, our
results provide functional and molecular evidence for a
conserved tissue-specific contribution of the BCL9 and
Pygo factors in canonicalWnt signaling in two distant ver-
tebrate species. In addition, our findings suggest a causa-
tive link between human congenital heart disease (CHD)
and the reported copy number changes in BCL9 at
1q21.1 and mutations in BCL9L (Christiansen et al.
2004; Brunet et al. 2009; Tomita-Mitchell et al. 2012; Dol-
cetti et al. 2013).
Results
BCL9 and Pygo perturbations cause developmental heart
defects in zebrafish and mice
To investigate the contribution of BCL9/9L proteins to
vertebrate heart development based on their repeated
association with CHD, we applied maximized CRISPR–
Cas9-mediated mutagenesis in zebrafish embryos to
generate bcl9 crispants (Fig. 1A–C; Burger et al. 2016):
We targeted both BCL9 family genes bcl9 and bcl9l with
individual single-guide RNAs (sgRNAs) by injection of
Cas9 ribonucleoprotein complexes into one-cell stage
zebrafish embryos and observed highly penetrant cardiac
phenotypes following somatic mutagenesis of bcl9
(Fig. 1B,C). We established mutant alleles for both bcl9
and bcl9l, featuring frameshift deletions in-between the
coding sequences for HD1 andHD2 (Fig. 1D), the domains
of BCL9 proteins that convey functional interaction with
Pygo and β-catenin, respectively (Kramps et al. 2002;
Cantù et al. 2014). We refer to these new alleles as
bcl9Δ29 and bcl9lΔ4; if not null, their BCL9/9L protein
products lost their HD2 and cannot bind β-catenin but
still interact with Pygo through the HD1 (Fig. 1D,E; Sup-
plemental Fig. S1; Kramps et al. 2002; Townsley et al.
2004b; Hoffmans et al. 2005; Mosimann et al. 2009).
Heterozygous bcl9Δ29 as well as homozygous bcl9lΔ4
zebrafish and their maternal–zygotic mutant offspring
(MZbcl9lΔ4) were viable and fertile with no obvious phe-
notypes (observed formore than four generations) (Supple-
mental Fig. S1). Zygotic mutant embryos homozygous for
bcl9Δ29 displayed unaltered expression of early cardiac
markers (nkx2.5, myh6/amhc, and gata4) at 24 h post-
fertilization (hpf) (Supplemental Fig. S2) and developed
seemingly normally until 48 hpf.
Between 56 and 72 hpf, we observed in homozygous
bcl9Δ29 mutants a variable incidence and expressivity of
pericardial edema (38%±12%) and misexpression of the
cardiac valve marker vcana (Supplemental Fig. S2). By
5 d post-fertilization (dpf), homozygous bcl9Δ29 embryos
showed highly penetrant craniofacial and cardiac defects
(n= 181 out of 879; 20.6% compared with Mendelian
25%; N=6) (Fig. 1F–I,N; Supplemental Movies 1, 2). Upon
detailed inspection, mutants displayed perturbed heart
looping with misaligned atrium and ventricle (Fig. 1I–R;
Supplemental Fig. S3) with more variable expressivity as
well as an underdeveloped cardiopharyngeal vasculature
(Fig. 1I–R; Supplemental Fig. S3). Detailed comparison of
dissected sibling hearts versus homozygousbcl9Δ29 hearts
at 5 dpf revealed slightly smaller ventricles and a signifi-
cantly smaller smooth muscle-based bulbus arteriosus
(BA) (Fig. 1S–V; Supplemental Fig. S3). Zygoticbcl9Δ29mu-
tants further developed a deformed pharyngeal skeleton,
with abnormal Meckel’s and palatoquadrate cartilage de-
velopment and fusion defects of the ceratohyal and cerato-
branchial 1 cartilage (Supplemental Fig. S4). Homozygous
bcl9Δ29 mutant embryos failed to properly inflate their
swimbladders (Fig. 1F–H; Supplemental Fig. S3) and invar-
iantly died at 11–12 dpf.Notably, double-mutant zebrafish
embryos homozygous for both bcl9Δ29 and bcl9lΔ4 looked
indistinguishable from homozygous bcl9Δ29mutants (Fig.
1F–H), suggesting a nonessential function ofbcl9l and that
no significant genetic compensation (Rossi et al. 2015) by
the paralog bcl9l occurs in bcl9Δ29 mutants.
To test for a potential role of the BCL9-interacting part-
ner Pygo1/2 during zebrafish development, we also gener-
ated mutant pygo1 and pygo2 alleles. We retained strains
that harbor alleles with frameshift mutations within the
essential N-terminal homology domain (NHD) and result
in a premature stop codon before the BCL9-binding C-ter-
minal PHD domain (Fig. 2A,B); we refer to these alleles as
Cantù et al.
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pygo1Δ5 and pygo2Δ1 (Fig. 2B–D). Embryos homozygous
for pygo2Δ1 and concomitantly heterozygous or homozy-
gous for pygo1Δ5 displayed cardiac defects and a spectrum
of craniofacial cartilage defects that, depending on expres-
sivity, mimicked those observed in homozygous bcl9Δ29
zebrafish mutants (Fig. 2E,F, Supplemental Fig. S4). In
contrast, zebrafish embryos homozygous for pygo1Δ5, ho-
mozygous for pygo2Δ, or homozygous for pygo1Δ5 with
one allele of pygo2Δ were indistinguishable from wild-
type siblings throughout development and developed
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C Figure 1. Mutations in bcl9 lead to cardiac
defects in zebrafish. (A) A CRISPR–Cas9-
mediated mutagenesis identified bcl9 as a
potential regulator of heart morphogenesis.
(B,C ) bcl9 crispants have heart-looping de-
fects, as visible in drl:mCherry transgenics,
leading to cardiac edema (asterisk) (lateral
view; anterior is to the left). (D) Schematic
representation of the bcl9 gene locus and
generation of the bcl9Δ29 germline allele. A
sgRNA was designed to target the coding
exon 6 between HD1 and HD2 of the zebra-
fish bcl9 gene. The locus is represented as
per annotation Zv10, with two isoforms
that differ in the first coding exon and the
untranslated regions (UTRs). The dotted
box represents a zoomed region of the locus,
and the red line marks the location of the
sgRNA to introduce the Cas9-mediated
cut, which resulted in the indicated frame-
shift (red box) followed by two stop codons
in the isolated bcl9Δ29 allele. In the isolated
allele, black boxes mark coding exons
(CDS), white boxes mark UTRs, blue boxes
represent the CDSs that contribute to HD1,
and purple boxes represent the CDSs that
contribute to HD2. (E) CrispRVariants pan-
el plot depiction of the bcl9Δ29 germline al-
lele with a 29-base-pair (bp) deletion. The
top shows genomic reference bcl9Δ29 (bcl9:
g.176663_176691), shown below. bcl9Δ29
features an out-of-frame deletion introduc-
ing a frameshift followed by 157 novel ami-
no acids terminated by two consecutive
stop codons, thus disconnecting HD1 from
HD2. The black box indicates the exact po-
sition of the sgRNA sequence, the gray-
shaded box indicates the 5′-NGG-3′ PAM
sequence, and the black line indicates the
predicted Cas9-induced double-strand
break position. (F–H) Bright-field images of
5-d post-fertilization (dpf) homozygous
bcl9Δ29 and bcl9Δ29;bcl9lΔ4 embryos and
their wild-type-looking siblings (lateral
views; anterior is to the left).Mutant embry-
os showed heart-looping defects and cardiac
edema (asterisks).Moreover,mutantembryosdidnot inflate their swimbladders (arrows), presumablydue to a failure in gaspingair because
of craniofacialmalformations (black arrowheads). (I–R) Single-plane illuminationmicroscopy (SPIM) images of hand2:EGFP;drl:mCherry-
expressing wild-type siblings and homozygous bcl9Δ29 embryos (ventral views; anterior is to the top; imaged after viable heart-stopping
BDM treatment). I andN depict maximum-intensity projections, and J, K,O, and P show close-ups of the dotted square in I andN, while
L,M,Q, and R depict optical sections at the atrio–ventricular canal level. Compared with siblings that form correctly looped hearts with
atrio–ventricular canal valves and abulbus arteriosus (BA;heart outlinedwith reddotted line;n= 4; J–M ),bcl9Δ29 embryos showheart-loop-
ingdefects (N–R) and craniofacialmalformations inboth cartilage andheadvascularization (n=8;N). (S–V ) Six-micrometerZ-confocal pro-
jections of sibling control (S) and homozygous bcl9Δ29 (T ) hearts at 5 dpf. Quantification of the ventricular (U ) and BA area (V ) in sibling
hearts (n=16) compared with homozygous bcl9Δ29 hearts (n= 15) shows that the BA area is significantly smaller in the bcl9Δ29 hearts.
(∗) P <0.0221, unpaired t-test withWelch correction. Each data point represents the averaged ventricular or BA area from one heart; quan-
tificationwas derived from three independent experiments.N =3. (ba) BA; (a) atrium; (v) ventricle; (av) atrio–ventricular canal. Bars:B,C,F–
H, 500 µm; I–R, 100 µm; S,T, 20 µm.
BCL9 and Pygo are required for heart development
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into fertile adults, including maternal–zygotic mutant
pygo1Δ5 animals (Supplemental Fig. S4). Taken together,
these data reveal select post-gastrulation defects and sen-
sitivity of cardiac development to functional BCL9 and
Pygo levels in zebrafish.
We next sought to delineate the cardiac phenotypes
caused by Pygo loss of function in mice. Combined loss
of function of Pygo1 and Pygo2 (Pygo1/2) leads to well-es-
tablished embryonic lethality at 13.5–14.5 d post-coitum
(dpc) (Li et al. 2007; Cantù et al. 2013). Our reanalysis of
these mutants revealed that Pygo1/2 mutant mouse em-
bryos develop severe heart defects between 10.5 and
14.5 dpc. Histology and three-dimensional reconstruction
of the heart documented hypoplastic ventricular myocar-
dium, dilated atria, shorter and thinner atrio–ventricular
valve leaflets, and aberrant chamber septation (Fig. 2G–J;
Supplemental Movies 3, 4; Supplemental Fig. S5). In addi-
tion, Pygo1/2mutant embryos displayed prominent OFT
anomalies such as transposition of the great arteries
(TGA; penetrance of 80%; n= 10) (Fig. 2K,L) and hypoplas-
tic aorta and pulmonary artery (penetrance of 90%; n= 10)
(Fig. 2M,N).
To test the requirement of PYGO1/2 binding to BCL9/
9L in heart formation, we used Bcl9/9l alleles carrying a
deletion in the region encoding the PYGO1/2-binding
HD1 (Bcl9/9l-ΔHD1) (Cantù et al. 2014). Bcl9/9l-ΔHD1-
homozygous mouse embryos died at the same stage as
Pygo1/2 mutants without apparent developmental delay
(13.5–14.5 dpc), and histological sections revealed under-
developed ventricle myocardium, dilated atria, defects
in the atrio–ventricular valve leaflets, and perturbed sep-
tation (Fig. 2O,P; Supplemental Fig. S6). These results in-
dicate that perturbing the cooperative action of BCL9/9L
and PYGO1/2 is sufficient to trigger cardiac defects in
E
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Figure 2. Pygo1/2 mutant zebrafish and
mouse embryos develop cardiac malforma-
tions reminiscent of CHD. (A) Schematic
of the tripartite complex comprised of β-cat-
enin, BCL9, and Pygo with their individual
interaction domains together tethered to a
WRE by TCF/LEF. (B) Schematic representa-
tion of the zebrafish pygo1 and pygo2 genes
with annotated NHDs and PHDs and the
Cas9 cutting site to generate mutants. The
gene locus is represented as per genome an-
notation Zv10, with the main isoforms of
both genes shown. See also the legend for
Figure 1B. (C,D) CrispRVariants panel plot
depictions of the germline alleles with a 5-
bp or 1-bp deletion in pygo1 and pygo2, re-
spectively. The top shows the genomic refer-
ence with the pygo1Δ5:g.2924_2928del and
pygo2Δ1:g.3191del alleles shown below.
Both alleles result in an out-of-frame dele-
tion introducing a frameshift in the CDS.
See also the legend for Figure 1C. (E,F )
Bright-field images of live pygo1Δ5;pygo2Δ1
double mutants reveal cardiac edema (aster-
isks), craniofacial defects (arrowheads), and
aberrant swim bladder inflation (arrows) as
detected in bcl9Δ29 mutants (lateral views;
anterior to the left). (G–J) Hematoxylin/eo-
sin-stained transverse sections of a murine
heart at 10.5 d post-coitum (dpc) (G,H) and
14.5 dpc (I,J). At 10.5 dpc, the development
of the heart and heart cushionwas still large-
ly normal in the mutants. At 14.5 dpc, the
mutants displayed markedly smaller and
thinner valves (dashed reduced compact
outline), reduced compact ventricular myo-
cardium (arrowhead), highly dilated atria,
and defective or absent atrial septum (asterisks). (RA) Right atrium; (LA) left atrium; (RV) right ventricle; (LV) left ventricle. (K–N) Gross
anatomical view of the heart and great vessels at 13.5/14.5 dpc as revealed by India ink injection.While normally the aorta (Ao) arises from
the left ventricle (LV), and the pulmonary artery (Pa) arises from the right ventricle (RV), mutants showed a classic transposition of the
great arteries (TGA; arrows) and hypoplastic aorta and pulmonary artery. (O,P) Schematic representation of the Bcl9/9l–Pygo1/2 interac-
tion (O), the molecular configuration of this interaction when the HD1 domain in Bcl9/9l is deleted in Bcl9/9l-ΔHD1mice (P), and heart
sections at 14 dpc, stained with hematoxylin/eosin. The abrogation of this interaction leads to a delayed chamber septation (asterisks),
hypoplastic myocardium (arrowhead), and valve deficiency. Bars: E,F, 250 µm.
Cantù et al.
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mice. Taken together, analyses in mice and zebrafish es-
tablish that perturbation of BCL9 and Pygo function caus-
es a range of heart defects in two evolutionarily distant
vertebrate species.
The BCL9–Pygo complex drives Wnt/β-catenin signaling
in developing hearts
Due to the β-catenin-independent roles of BCL9 and Pygo
proteins (Song et al. 2007; Cantù et al. 2013, 2014, 2017),
we cannot formally link the phenotypes resulting from
our mutants to defective canonical Wnt signaling. Since
BCL9/9L can act as linker proteins connecting β-catenin
and Pygo (Bienz 2006), we aimed at specifically testing
the concurrent requirement of connecting these interac-
tion partners.
To do so, we generated a trans-heterozygous allelic con-
figuration for both Bcl9 and Bcl9l, in which one allele car-
ries a deletion of the HD1 (essential for PYGO binding),
while the other lacks the HD2 (essential for β-catenin
binding) (Fig. 3A,B; Cantù et al. 2014).Note thatmice dou-
ble-heterozygous for deletion of the HD1 (Bcl9ΔHD1/+;
Bcl9lΔHD1/+; referred to here as Bcl9/9l-ΔHD1/+) or the
HD2 (Bcl9ΔHD2/+;Bcl9lΔHD2/+; referred to here as Bcl9/9l-
ΔHD2/+) are viable and fertile. Crossing Bcl9/9l-ΔHD1/+
and Bcl9/9l-ΔHD2/+ mice should lead to trans-heterozy-
gous progeny (in one out of 16 embryos) in which both
domain deletions are present (Bcl9ΔHD1/ΔHD2;Bcl9lΔHD1/
ΔHD2; referred to here asBcl9/9l-ΔHD1/ΔHD2). The result-
ing protein products can form either BCL9–β-catenin or
BCL9–PYGO interactions but not the full tripartite tran-
scriptional module (Fig. 3B), allowing us to test the devel-
opmental requirement of the β-catenin–BCL9–Pygo
complex.
From these crosses, we never recovered Bcl9/9l-ΔHD1/
ΔHD2 pups (Fig. 3B, bottom table), indicating embryonic
lethality. Even though at lower numbers than the expect-
ed Mendelian ratio, Bcl9/9l-ΔHD1/ΔHD2 embryos did
reach the 13.5–14.5 dpc stage (Fig. 3B) and displayed heart
defects, including ventricular myocardium hypoplasia
and smaller and thinner valve leaflets (Fig. 3C–F; Supple-
mental Fig. S6). This indicated that, for adequate develop-
ment of these cardiac structures, BCL9/9L are required to
physically connect PYGO proteins to β-catenin. Further
relating these defects to perturbed canonical Wnt signal-
ing was the reduced expression of the in vivo BATgal re-
porter (sensing nuclear β-catenin activity) in Bcl9/9l-
ΔHD1/ΔHD2 mutants in cardiac valve progenitors, a re-
gion with active canonical Wnt signaling (Fig. 3D,F;
Bosada et al. 2016). Moreover, single-molecule mRNA in
situ hybridization (ISH) of Axin2, a prototypical pan-
canonical Wnt target gene, confirmed that, at the time of
analysis, canonical Wnt signaling activity was decreased
in valve progenitors but not in other tissues with active
Wnt signaling, such as the skin (Fig. 3G–L; Zhu et al.
2014). In addition to cardiac defects, we observed under-
developed limbs (Fig. 3M–R), andmild skeletal malforma-
tions including shortened radius and ulna bones, incorrect
specification of digit number and bifid ribs (Supplemental
Fig. S7). Notably, while BATgal expression remained
broadly unaffected in Bcl9/9l-ΔHD1/ΔHD2 embryos, its
reduction occurred as for the cardiac valve progenitors
mainly in the malformed tissues, including the develop-
ing forelimbs (Fig. 3M–R). Correspondingly, in bcl9Δ29
mutant zebrafish at 5 dpf, the pattern and strength of the
canonical Wnt signaling reporter Tg(7xTCF-Xla.Siam:
nlsmCherry)ia5 (referred to here as TCF-siam:Red) (Moro
et al. 2012) remained globally unaffected yet showed
mild reduction or pattern changes in the atrio–ventricular
valve region, theOFT, and craniofacial structures (Fig. 3S–
V). Taken together, these data indicate that disrupting the
β-catenin–BCL9–Pygo complex in vivohas aminor impact
on overall Wnt signaling but selectively perturbs individ-
ual domains of active canonical Wnt signaling.
To independently disrupt the protein–protein interac-
tion between BCL9 and β-catenin in zebrafish, we used
the chemical compound LH-2-40 (compound 22) (Hoggard
et al. 2015) that acts as a uniquely selective inhibitor of
the BCL9-HD2 interaction with the β-catenin arm repeats
1 and 2 (Hoggard et al. 2015; Wisniewski et al. 2016). We
treated wild-type zebrafish embryos with LH-2-40 at
concentrations ranging from 1 to 50 µM at distinct devel-
opmental time points: four-cell stage, shield stage, and
18-somite stage, respectively. Pregastrulation and gastru-
lation stage treatment with LH-2-40 did not induce any
observable gastrulation defects (Fig. 4A,B); in contrast, at
5 dpf, treated embryos recapitulated the bcl9Δ29 mutant
phenotypes in a dose-dependentmanner (Fig. 4C–H). Con-
sistent with our genetic observations, LH-2-40-treated
embryos displayed altered TCF-siam:Red expression in
the atrio–ventricular valve region and in craniofacial
structures at 3 and 5 dpf (Fig. 4I–P) as well as phenotypes
resembling those observed in bcl9Δ29 homozygous embry-
os (Supplemental Fig. S8).
While we cannot rule out influence by Wnt/β-catenin-
independent functions of BCL9 and Pygo, our results
are consistent with their joint requirement for β-catenin-
dependent signaling and emphasize that disconnecting
β-catenin from the BCL9–Pygo module during both
mouse and zebrafish development does not cause system-
ic perturbation of canonical Wnt signaling but has selec-
tive impact on isolated cell types, including heart
formation.
Different cardiac lineages are sensitive to mutations
in BCL9 and Pygo
β-Catenin-dependent target gene control is required at dif-
ferent stages of vertebrate heart development, including
the initiation of the cardiac program within the lateral
plate mesoderm (LPM), chamber formation, and valve de-
velopment (Hurlstone et al. 2003; Armstrong and Bischoff
2004; Gessert and Kühl 2010; Bosada et al. 2016). Tran-
scriptome analysis of anterior embryo tissues (including
theheart, pharyngeal arches, pectoral fins, andcraniofacial
structures) (Fig. 5A) from bcl9Δ29 mutant zebrafish at 54
hpf compared with wild-type siblings detected deregula-
tion of 157 genes (83 genes down, fold change <0.5; 74
genes up, fold change >2.5) (Fig. 5B; Supplemental Fig.
S9). The deregulated genes fall within different annotated
BCL9 and Pygo are required for heart development
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gene expression categories, including the heart, LPM, and
neural crest (Supplemental Tables S1, S2).
In mammals and chickens, cardiac neural crest (CNC)
cells contribute to OFT development and septation
(Waldo et al. 2005; Bradshaw et al. 2009). We tested the re-
quirement of the PYGO/BCL9 complex in CNC cells by
combining the Pygo-flox and the BCL9-ΔHD1 strains
with the neural crest-specificWnt1-Cre driver. Pygo1flox/
flox; Pygo2flox/flox;Wnt1-CreTg/
∗
(referred to here as Wnt1-
Cre;Pygo-flox) and Bcl9ΔHD1/flox;Bcl9l ΔHD1/flox;Wnt1-
CreTg/
∗
(referred to here as Wnt1-Cre;Bcl9/9l-ΔHD1/flox)
displayed embryonic lethality at 13.5/14.5 dpc and fea-
tured heart malformations thatmorphologically recapitu-
lated the constitutive loss of Pygo1/2 (Fig. 5C–F). The
expression of the CNC marker Pax3 (Bradshaw et al.
2009) was significantly decreased in migrating CNC cells
at 10.5 dpc in Pygo1/2 knockout embryos (Fig. 5G–J).
These results indicate that BCL9 and PYGO loss in the
CNC is sufficient to perturb the OFT, valves, and cardiac
septation.
To test for the contribution of these proteins in LPM-de-
rived heart progenitors, we combined the Bcl9/9l-flox
E F
BA
C
G H J KI L
D
M N
O
P
S
T
U V
Q
R
Figure 3. The BCL9–Pygo complex drives
Wnt/β-catenin transcription during heart
development. (A) Schematic representation
of the β-catenin transcriptional complex to
outline the experimental strategy. BCL9/9l
simultaneously interacts with Pygo1/2
and β-catenin via theHD1 andHD2, respec-
tively. (B) In Bcl9/9l-Δ1/Δ2mice, no Bcl9/9l
molecule can simultaneously bind Pygo1/2
and β-catenin; the deletion of the HD2 or
HD1 abrogates Bcl9/9l binding to β-catenin
(left panel) or Pygo1/2 (right panel), respec-
tively. Bcl9/9l-Δ1/Δ2 embryos are never
found after 14.5 dpc (table). (C–F ) Hematox-
ylin/eosin staining on heart sections of con-
trol (C ) and Bcl9/9l-Δ1/Δ2 (E) embryos at
13.5 dpc. Bcl9/9l-Δ1/Δ2 embryos have pro-
nounced heart defects, with thinned myo-
cardium of the ventricular walls and
malformations of the forming septum, the
atrio–ventricular valves, and OFT. The ex-
pression of in vivo BATgal Wnt reporter in
the OFT region is markedly reduced in
Bcl9/9l-Δ1/Δ2 mutant (F ) compared with
control (D) hearts. (RA) Right atrium; (LA)
left atrium; (RV) right ventricle; (LV) left
ventricle. (G–L) Axin2 expression (detected
by single-molecule mRNA ISH) in wild-
type and Bcl9/9l-Δ1/Δ2 OFT valves (G,J)
and skin (H,K ) at 13.5 dpc. Green boxes
are drawn around transversal sections of in-
dividual valves of the OFT (G,J) and in skin
sections from the limbs (H,K ) for quantifi-
cation of fluorescence intensity levels (I,
L). Axin2 expression is strongly reduced in
the valves of Bcl9/9l-Δ1/Δ2 embryos (J),
while reduction in the skin is mild (K ). (I,
L) The quantification of the ratio between
Axin2 expression in the valves and the
skin in the different genotypes reveals a sig-
nificant reduction of Axin2 expression in
Bcl9/9l-Δ1/Δ2 valves. (∗) P-value < 0.05.
(M–R) In vivo BATgal reporter expression
in 13.5-dpc wild-type (M–O) and Bcl9/9l-
Δ1/Δ2 mutant (P–R) embryos. Mutant em-
bryos have a slightly decreased reporter ex-
pression, but BATgal reporter expression is
generally retained in most tissues. Reduced BATgal activity is observed in the craniofacial region (N,Q) and the forelimbs (O,R). Loss of
canonicalWnt signaling transcription in the forelimbs is accompanied by severe developmental limb defects inBcl9/9l-Δ1/Δ2 embryos (cf.
O and R). (S–V ) Fluorescent and bright-field images of TCF-siam:Red bcl9Δ29 and wild-type zebrafish embryo lateral (S,T ) and ventral (U,
V ) views; anterior is to the left. TCF reporter activity is specifically reduced in the cardiac OFT (arrow) and craniofacial apparatus (arrow-
heads) and altered in the atrio–ventricular valve (asterisks). Bars: C–F,G,H,J,K, 100 µm; S–V, 200 µm.
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conditional strain (Deka et al. 2010; Cantù et al. 2014)
with Nkx2.5-Cre, in which Cre recombinase is active in
the expression domain of the cardiac homeobox gene
Nkx2.5 at early cardiac crescent stages (∼7.5 dpc) (Stanley
et al. 2002). Nkx2.5-Cre-mediated Bcl9/9l recombination
led to embryonic lethality accompanied by cardiac mal-
formations, including thinner myocardium (Fig. 5K–N).
The effect on the compact myocardium upon Bcl9/9l
mutations is consistent with the role of canonical Wnt
signaling in driving cardiomyocyte proliferation while
preventing terminal maturation (Naito et al. 2006; Ges-
sert and Kühl 2010).
Taken together, these results establish that the BCL9–
PYGO complex connected to β-catenin is required in
both migrating CNC cells and early mesodermal Nkx2.5-
expressing cardiac progenitors, two key lineageswhose in-
terplay is crucial during mammalian heart development
(Brade et al. 2013).
The tripartite β-catenin–BCL9–Pygo complex controls
cardiac regulators
We next sought to gain insight into the transcriptional
changes occurring in the developing cardiac lineages
upon perturbation of the β-catenin–BCL9–Pygo module.
RNA sequencing (RNA-seq) of the developing heart
tube and adjacent branchial arches 3–6 (through which
CNCcellsmigrate toward the loping heart) from constitu-
tive Pygo1/2mutant mice and control siblings at 10.5 dpc
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Figure 4. Chemical manipulation of zebrafish heart development by Bcl9–β-catenin inhibitor LH-2-40. (A,B) Treatment with 10 µM LH-
2-40 from the two- to four-cell stages does not result in gastrulation defects (lateral views). (C–E) Bright-field images of 5-dpf DMSO con-
trols (C ) and representative embryos treatedwith 10 µMLH-2-40 from the four-cell stage on (D,E), as assessed for phenotype classes (quan-
tified in F–H) (lateral views; anterior is to the left). Phenotypes in LH-2-40-treated embryos become visible at 5 dpf, comparable with
phenotypes observed in bcl9Δ29 mutants. LH-2-40-treated embryos show a variable phenotype expressivity, with mild to strong swim
bladder inflation defects (arrowheads;D,E) linked with variable craniofacial defects (asterisks;D,E, cf. control inC ). (F–J) Similar dose-de-
pendent phenotype penetrance and expressivity are observed after Bcl9 inhibition at the four-cell, shield, and 18-somite (18 ss) stages, sug-
gesting that the observed phenotypes result fromperturbed Bcl9 function in craniofacial and heart development after somitogenesis. Mild
phenotypes are characterized by mild craniofacial and swim bladder inflation defects. (D) Both phenotypes are more pronounced in the
medium phenotype class. (E) Strong phenotypes are characterized by strong craniofacial defects and a complete failure to inflate the
swim bladder. (I–P) Fluorescent and bright-field images of TCF:siamRed Bcl9-inhibited (K,L,O,P) and DMSO-treated (I,J,M,N) wild-
type siblings at 3 and 5 dpf (lateral views; anterior is to the left). TCF reporter activity is severely reduced in the atrio–ventricular valve
at 3 dpf (asterisks; I,K ) and altered in the craniofacial cartilage (arrowheads; I,K ). At 5 dpf, the TCF reporter is aberrantly patterned in
the atrio–ventricular valve (asterisks;M,O) and fins (arrowheads;M,O). Bars: C–E,I–P, 200 µm; A,B, 500 µm.
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(n= 4) (Fig. 6A) revealed a discrete set of 65 deregulated
genes, 44 of which were down-regulated and 21 of which
were up-regulated (P-value < 0.05; fold change <0.66 and
>1.5) (Fig. 6B). Gene ontology (GO) analysis associated a
broader group of the most deregulated genes with cardiac
ventricle development, embryonic limb morphogenesis,
and skeletal system development, recapitulating the
biological processes perturbed upon bcl9 mutation in
zebrafish (Fig. 6C). Notably, the down-regulated genes
comprised several encoding for mesodermal and neural
crest transcription factors crucial for heart development,
including Pitx2, Hand2, Msx1, and Prrx1 (Fig. 6B,C; Kio-
ussi et al. 2002; Chen et al. 2007; Andersen et al. 2013;
Ocaña et al. 2017). We confirmed the down-regulation
of the most relevant genes by quantitative RT–PCR
(qRT–PCR) and ISH (Fig. 6D–F). RNA-seq of Pygo1/2mu-
tant hearts at 12.5 dpc—when septation, valve formation,
and myocardium proliferation and thickening have oc-
curred (Gessert and Kühl 2010)—showed more profound
gene expression changes consistent with progressive dete-
rioration of cardiac development (533 genes down; 1064
genes up; P-value < 0.05; n= 3) (Supplemental Table S3).
To chart the genomic locations that are bound by the
β-catenin–BCL9–PYGO complex, we performed chroma-
tin immunoprecipitation (ChIP) followed by sequencing
(ChIP-seq) in duplicate for β-catenin and PYGO2 at 10.5
dpc from dissected pharyngeal arches 3–6 and the develop-
ing heart (Fig. 7A). ChIP-seq analysis assigned a total
of 982 genes associated with loci occupied by β-catenin
and 5252 genes associated with loci occupied by PYGO2
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Figure 5. The Bcl9–Pygo complex acts in neural crest and cardiac heart progenitor cells. (A) Schematic representation of the RNA se-
quencing (RNA-seq) approach used for bcl9Δ29mutant zebrafish embryos. RNA extraction was performed onmanually dissected anterior
structures of 54-hpf embryos as indicated by the dashed box. (B) Comparing three independent biological replicates revealed 157 differ-
entially expressed (74 up-regulated and 83 down-regulated) genes between wild-type and bcl9Δ29 mutants as represented in the volcano
plot. Genes associatedwith cardiac development are highlighted. (C–F ) Hematoxylin/eosin staining of heart sections of control (C,E) com-
pared withWnt1-Cre; Pygo1/2-flox (D) and Bcl9/9l-ΔHD1/flox (F ) 13.5-dpc siblings. (G–J) Pax3 expression in 10.5-dpc embryos in the re-
gion of branchial arches: view of whole-mount mRNA ISH of control (G) compared with Pygo1/2 knockout (KO; I ) siblings. H and J are
magnified insets of the regionsmarkedwith dashed squares inG and I, respectively. (K–N) Hematoxylin/eosin staining of heart sections of
control (K ) compared with Nkx2.5-Cre; Bcl9/9l-flox (L–N) 13.5-dpc siblings.
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(Fig. 7B); the broader chromatin association of PYGO2 is
in line with the known role of this factor as a widely de-
ployed chromatin code reader (Bienz 2006; Fiedler et al.
2015) and its Wnt-independent functions (Cantù et al.
2013). Nonetheless, the genome-wide peak distribution
was similar between β-catenin and PYGO2 (Fig. 7C), and
their co-occupancy occurred at 59% of all β-catenin target
genes (577 out of 982) (Fig. 7B,C), including at those loci
found in the vicinity of canonical Wnt targets such as
Axin2 and Lef1 (Fig. 7D). These peaks correspond to previ-
ously describedWREs (Hovanes et al. 2001; Jho et al. 2002)
and display the consensus binding sequence of the TCF/
LEF transcription factors as anticipated for β-catenin-re-
sponsive elements (Fig. 7E). Therefore, while systemic ca-
nonical Wnt target genes retain most of their activity in
Pygo and Bcl9mutants, these data combined with the tis-
sue-specific loss of Axin2 expression in Bcl9/9l mutants
(Fig. 3G–L) indicate a tissue-specific contribution from
the β-catenin–BCL9–PYGO complex in branchial arches
and heart cells. GO analysis of target genes thatwere asso-
ciated with β-catenin/PYGO2-co-occupied regions (based
on proximity to known transcriptional start sites [TSSs])
revealed enrichment for genes involved in heart morpho-
genesis, valve formation, cardiac chamber septation, and
skeletal development (Fig. 7F,G). The intersecting data
of the RNA-seq and ChIP-seq experiments converged on
a short list of heart-associated regulatory genes that are
potentially controlled by the β-catenin–BCL9–PYGO
complex, includingMsx1, Prrx1, Six1, and Six2 (Fig. 7H).
Collectively, our data support the notion that a subset
of heart-specific transcriptional regulators is controlled
by BCL9 and Pygo as a consequence of their context-de-
pendent interaction with β-catenin.
Discussion
Numerous proteins have been shown to functionwith nu-
clear β-catenin, but only a few are considered universal
core components of the canonicalWnt pathway. Contrary
to themandatory requirement inDrosophila (Fiedler et al.
2015; van Tienen et al. 2017), genetic evidence in mam-
mals has questioned the significance and involvement of
BCL9-mediated tethering of the histone reader Pygo to
β-catenin in Wnt target gene control (Song et al. 2007;
Cantù et al. 2014, 2017). In parallel, in vivo evidence for
BCL9 and Pygo function has suggested divergent func-
tions for these proteins in different model organisms:
While overexpression and morpholino-based experiments
in zebrafish and Xenopus have assigned β-catenin-depen-
dent functions for BCL9 and Pygo proteins already during
gastrulation, loss-of-function studies during mouse devel-
opment have uncovered mainly Wnt-independent pheno-
types (Brembeck et al. 2004; Kennedy et al. 2010; Cantù
et al. 2014). To date, no clear consensus of their function
during vertebrate development has emerged. Here, by
combining genetic and chemical loss-of-function studies
in both zebrafish and mice, we revealed a conserved
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D Figure 6. The Pygo–BCL9–β-catenin tran-
scriptional complex controls the expression
of a heart-specific genetic program. (A) Sche-
matic representation of the RNA-seq ap-
proach used for Pygo1/2 knockout (KO)
mutant mouse embryos. RNA extraction
was performed on manually dissected bran-
chial arches 3–6 and hearts of 10.5-dpc em-
bryos, as indicated by the dashed outline.
(B) Volcano plot depicting the set of up-regu-
lated (23) and down-regulated (43) genes in
Pygo1/2 knockout (KO) mouse embryos
with a fold change of <0.66 and >1.5. P<
0.05. n=4. (C ) GO-based categorization of a
broader group consisting of the 500most de-
regulated genes (based on P-value) indicates
the biological processes affected. The total
bar length indicates the number of genes
that categorize to the indicated GO term,
the red line indicates the expected number
of genes in a random deep sequencing analy-
sis, and the color of the bar indicates the P-
value for the gene enrichment in our analy-
sis. (D) qRT–PCRvalidationofa subsetof tar-
get genes. mRNA expression level was
calculated based on Gapdh and is shown as
arbitrary units (AU). (∗) P<0.05; (∗∗) P<0.01.
(E,F ) Whole-mount ISH in 10.5-dpc control
(E) andPygo1/2knockout (KO;F )mouse em-
bryos shows tissue-specific (branchial arch-
es) down-regulation of the target gene Pitx2.
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contribution of BCL9 and Pygo proteins as context-depen-
dent regulators of Wnt/β-catenin signaling in vertebrates.
The phenotypes resulting from abrogating their function
imply that the Pygo–BCL9–β-catenin complex acts as a
context-dependent transcriptional regulator during tis-
sue-specific processes, in particular during heart develop-
ment. Our in vivo data clarify, consolidate, and extend
previous work on BCL9 and Pygo protein function. Addi-
tionally, our results implicate perturbed BCL9/9L func-
tion as potentially causative for human CHD, as it
occurs in copy number variants of the chromosome region
1q21.1.
Previous work and our results confirm that various ge-
netic loss-of-function permutations of BCL9 and PYGO
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Figure 7. PYGO2 and β-catenin co-occupy regulatory regions of Wnt target and heart-specific genes. (A) Schematic representation of the
ChIP-seq approach. Branchial arches 3–6 and hearts of 10.5-dpc wild-type embryos were dissected manually as indicated by the dashed
outline. Immunoprecipitation was performed for β-catenin and PYGO2. (B) Venn diagram depicting the overlap between β-catenin and
PYGO2 target genes. (C ) Genomic distribution of β-catenin, PYGO2 and overlapping peak locations indicates prominent binding to reg-
ulatory regions foundwithin promoters or introns. (D) β-Catenin and PYGO2ChIP-seq peaks on theWREs of the prototypical target genes
Axin2 (left panel) and Lef1 (right panel). Red columns indicate the position of previously described WREs. (E) The binding motif of TCF/
LEF transcription factors is present within β-catenin/PYGO2 overlapping peaks. (F ) GO analysis of common β-catenin and PYGO2 target
genes reveals the direct regulation of processes associatedwith heart development. The total bar length indicates the number of genes that
categorize to the indicated GO term, the red line indicates the expected number of genes in a random deep sequencing analysis, and the
color of the bar indicates the P-value for the gene enrichment in our analysis. (G) A list of the 30 direct PYGO2/β-catenin target genes that
have been implicated previously in heart development. (H) β-Catenin and PYGO2ChIP peaks (red columns) within the regulatory regions
of genes involved in cardiac development and found down-regulated upon Pygo2 loss (see also Fig. 6). ChIP-seq custom tracks were visu-
alized in the Integrative Genomic Viewer genome browser.
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proteins do not perturb gastrulation in mice (Figs. 2,3;
Cantù et al. 2014). In zebrafish, we generated mutants
with a premature stop codon between the HD1 and HD2
coding sequences of bcl9 and bcl9l; these mutations un-
couple BCL9/9L–PYGO1/2 from engaging with β-catenin.
We did not detect any gastrulation defects as reported pre-
viously for morpholino knockdown of Xenopus XBcl9
and zebrafish bcl9l (Supplemental Fig. S1; Brembeck
et al. 2004; Kennedy et al. 2010). Double-mutant bcl9/
bcl9l zebrafish and specific chemical interruption of
the BCL9/9L–β-catenin interaction by LH-4-20 (Hoggard
et al. 2015) phenocopy the bcl9Δ29 mutant phenotype
(Fig. 4; Supplemental Fig. S6). We cannot rule out that po-
tentially high levels of maternal BCL9 are sufficient for
gastrulation stage functions;we further cannot rule out ge-
netic compensation during gastrulation for bcl9 by bcl9l
and vice versa (Rossi et al. 2015) despite the absence of
such an effect at later stages in the doublemutants (Fig. 1).
Both zebrafish and mouse embryos with perturbed
BCL9 and Pygo maintain broad transcriptional activity
of β-catenin (Figs. 3, 4). Nonetheless, following our obser-
vation of cardiac defects in interaction-perturbing Bcl9
and Pygo mutants, transcriptome analysis (Fig. 6) and
chromatin occupancy of β-catenin and PYGO (a challeng-
ing experiment in vivo for β-catenin due to its indirect
DNA binding) (Fig. 7) uncovered a collection of cardiac
and pharyngeal genes sensitive to disrupting the β-cate-
nin–BCL9–Pygo complex. Among these, we found com-
mon pan-β-catenin target genes, including Axin2 and
Lef1. Importantly however, we predominantly uncovered
genes associated with tissue-specific functions (Fig. 7).
Our data support amodel of canonicalWnt target gene ex-
pression by context-dependent nuclear β-catenin interac-
tions and define BCL9 and Pygo proteins as selectively
required β-catenin interactors in vertebrate heart develop-
ment. Of note, cardiac defects in mice, such as atrio–ven-
tricular valve malformations, lead to embryonic lethality
between 13.5 and 16.5 dpc (Ranger et al. 1998; Combs and
Yutzey 2009), suggesting that the cardiac malformations
could indeed cause the lethality of Pygo1/2 mutant and
Bcl9/9l-ΔHD1 and embryos. The limb and additional skel-
etal phenotypes observed in our mutants deserve detailed
future analysis. Our findings further emphasize that BCL9
and Pygo cannot be strictly defined as core components of
the canonical Wnt pathway; whether their mandatory
contribution to canonical Wnt signaling in Drosophila
represents an ancestral function or a specialization war-
rants further investigation.
Of note, in nonsyndromic sporadic cases of humanCHD
(withorwithout additional extracardiacphenotypes), copy
number gains and losses have repeatedly been found in the
genomic region 1q21.1 that includes the BCL9 locus
(Christiansen et al. 2004; Mefford et al. 2008; Brunet
et al. 2009; Greenway et al. 2009; Soemedi et al. 2012;
Tomita-Mitchell et al. 2012; Dolcetti et al. 2013). Copy
number variants (CNVs) that lead to either loss or gain of
BCL9 copies could perturb the sensitive balance of the
PYGO-interacting β-catenin coactivator function of
BCL9 during human heart development. Furthermore,
mutations in BCL9L, including changes in the HD1,
have been genetically linked in a small pedigree to hetero-
taxia (HTX) with congenital cardiac malformations in-
cluding ventricular and atrial septal defects (Saunders
et al. 2012). Our genetic and functional data reveal a
causative connection between varying Wnt/β-catenin
signaling levels by mutations in Bcl9 and Pygo with
developmental heart defects in both zebrafish and mice;
therefore, our findings indicate that CNVs of, or muta-
tions in, BCL9 and BCL9L might contribute to the etiol-
ogy of human CHD through tissue-specific perturbation
of canonical Wnt signaling.
Materials and methods
Zebrafish husbandry and transgenic strains
All zebrafish embryos were raised and maintained in E3 medium
at 28.5°C without light cycle essentially as described previously
(Westerfield 2007). All experiments were performed on embryos
up to 5 dpf and older larvae kept only for raising mating pairs in
agreement with procedures mandated by the veterinary office of
the University of Zürich and the Canton of Zürich. Embryo stag-
ing was done according to morphological characteristics corre-
sponding to hours post-fertilization or days post-fertilization as
described previously (Kimmel et al. 1995). Previously established
transgenic zebrafish lines used for this study included Tg
(-6.35drl:EGFP) (Mosimann et al. 2015), Tg(-6.35drl:mCherry)
(Sánchez-Iranzo et al. 2018), Tg(7xTCF-Xla.Siam:nlsmCherry)ia5
(Moro et al. 2012), and TgBAC(hand2:EGFP) (Yin et al. 2010).
CRISPR–Cas9 mutagenesis in zebrafish
CRISPR–Cas9 mutagenesis was essentially performed as de-
scribed in Burger et al. (2016). Oligo-based sgRNA templates (Bas-
sett et al. 2013) were generated by PCR amplification using the
invariant reverse primer 5′-AAAAGCACCGACTCGGTGCCA
CTTTTTCAAGTTGATAACGGACTAGCCTT-3′ and forward
primers of the sequence 5′-GAAATATTTAGGTGACACTATA-
(N20–22)-GTTTTAGAGCTAGAAATAGC-3′, with N represent-
ing the 20 nucleotides of the sgRNA target sequence plus up to
2 Gs at the 5′ end for successful T7 in vitro transcription. sgRNA
(plus added 5′ Gs in brackets) sequences were (1) bcl9 (5′-[G]
GCCTGACTGCGCTACTTTAG-3′), (2) bcl9l (5′-[G]GATTTAG
GTGTGCCAATCGG-3′), (3) pygo1 (5′-GGACTTCCCAGTAGC
AGCCC-3′), and (4) pygo2 (5′-[G]GCCGATGGTTGACCACC
TGG-3′).
Crispants were raised to adulthood and crossed to wild type to
make F1 germline mutants. All analyses and experiments were
taken out on F2 mutant generations and beyond. Genotyping
primerswere designed to amplify target regions ofmutated alleles
that were subsequently analyzed via sequencing (for pygo1Δ1) or
high-percentage gel electrophoresis (for bcl9Δ29), or allele-specific
primers were designed to bind to mutated versus wild-type se-
quences specifically (for bcl9lΔ4 and pygo1Δ5). The primers used
were (1) bcl9 (5′-GGTGGAAAGCCCCAACTCC-3′ [fwd] and 5′-
CGTGTGCCAACTGCTGGTGG-3′ ]rev]), (2) bcl9l (5′-CACTTG
CAGGTGCTGCATGG-3′ [fwd] and 5′-CTTTGAGATTTAGGT
GTGCCGG-3′ [rev]), (3)pygo1 (5′-CACTTTTACTGACCCCCAC
AC-3′ [fwd] and 5′-GGACTTCCCAGTAGCAGGA-3′ [rev]), and
(4) pygo2 (5′-GCCCAGAGAAAAAGAAGAGG-3′ [fwd] and
5′-GCTGTCCACTTCCAGGTCC-3′ [rev]). Genotyping results
were analyzed and alleles visualized using CrispRVariantsLite
(Lindsay et al. 2016). The final mutant designations are bcl9Δ29
(zh714), bcl9lΔ4 (zh715), pygo1Δ5 (zh716), and pygo2Δ1 (zh717).
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Chemical treatments
Wild-type and Tg(7xTCF-Xla.Siam:nlsmCherry)ia5 embryos and
embryos obtained from bcl9Δ29 heterozygous incrosses were
treated with LH-2-40 to globally perturb Bcl9ΔHD2–β-catenin in-
teraction at the respective developmental stages. LH-2-40, origi-
nally called compound 22 as referred to in Hoggard et al. (2015),
was kindly provided by the laboratory of Dr. Haitao Ji (Moffitt
Cancer Center, Tampa, FL). Single-use LH-2-40 stocks were
kept at a concentration of 100mMinDMSOat−80°C and thawed
and diluted in E3 to aworking concentration indicated in individ-
ual experiments directly before administration to the embryos.
Alcian blue staining
Wild-type, bcl9, and pygo1/2 mutant zebrafish embryos were
fixed in 4% paraformaldehyde (PFA) overnight at 4°C and, after
washing in 0.1% PBS-Tween (PBST), stained in Alcian blue stain-
ing solution (0.1 g of Alcian blue, 70 mL of ethanol, 30 mL of gla-
cial acetic acid) overnight at room temperature. Embryos were
washed in ethanol, transferred through an ethanol series to
PBST, and subsequently bleached in hydrogen peroxide (3%
H2O2 in 1% KOH in PBS) for 1 h or until pigments of specimens
became transparent.
Zebrafish whole-mount ISH
First strand complementary DNA (cDNA) was generated from
pooled zebrafishRNA isolated fromdifferent developmental stag-
es using SuperScript III first strand synthesis kit (Invitrogen).
DNA templates were generated using first strand cDNA as a
PCR template and the following primers: vcana (5′-TTACGTA
TGCAGCCTTCTCG-3′ and 5′-GGTTCATGGGGTAACTGT
GG-3′), myh6 (5′-ACGGATCAAGTAAGCGAAGG-3′ and 5′-
GTTCCTCCAGTTCGTTTTGC-3′), gata4 (5′-GAGCTGCGTC
TTACGAGTCC-3′ and CAGACTGGCTCTCCTTCTGC-3′),
and spry4 (5′-ACTGATGAGGACGAGGAAGG-3′ and 5′-GAC
TCGGAATCCTTCAGTGG-3′). For in vitro transcription initia-
tion, the T7 RNA polymerase promoter 5′-TAATACGACTCAC
TATAGGG-3′ was added to the 5′ ends of reverse primers. The
DNA template for nkx2.5was amplified usingT3 andT7 primers.
PCR reactions were performed under standard conditions using
Phusion high-fidelity DNA polymerase (Thermo Fisher Scien-
tific). RNA probes were generated via overnight incubation at
37°C using 20U/µLT7RNA polymerase (Roche) and digoxigenin
(DIG)-labeled dNTPs (Roche). The resulting RNAwas precipitat-
ed in lithium chloride and ethanol.
Embryos were fixed in 4% PFA overnight at 4°C, transferred
into 100% methanol, and stored at −20°C. ISH of whole-mount
zebrafish embryos was performed essentially according to stan-
dard protocols (Thisse and Thisse 2008).
Immunostaining on dissected zebrafish hearts
Hearts from 120-hpf zebrafish embryos were dissected in
Tyrode’s solution [136 mM NaCl, 5.4 mM KCl, 1 mM MgCl2 ×
6H2O, 5 mM D(+) glucose, 10 mM HEPES, 0.3 mM Na2HPO4×
2H2O, 1.8 mM CaCl2 × 2H2O at pH 7.4] with 20 mg/mL BSA
and fixed with Shandon Glyo-Fixx (Thermo Fisher Scientific,
9990920) for 20 min at room temperature. Hearts were blocked
in blocking buffer containing 5% normal goat serum, 20 mg/
mLBSA, 1%DMSO, and 0.1%Tween-20 in PBS followed byover-
night incubation at 4°Cwith primary antibodies diluted in block-
ing buffer. Primary antibodies used were mouse anti-MHC (1:50;
Developmental StudiesHybridoma Bank,MF20 supernatant) and
rabbit anti-PKC-ζ (1:100; Santa Cruz Biotechnology, sc-216).
Hearts were washed three times in blocking buffer, incubated
with Alexa-conjugated secondary antibodies for 4 h and DAPI
in PBS for 20 min at room temperature, washed again three times
with blocking buffer, and mounted in the ProLong Gold anti-fade
reagent (Thermo Fisher Scientific, P36934).
Microscopy and data processing
Bright-field, basic fluorescence, and ISH imaging was performed
using a Leica M205FA equipped with a DFC450 C camera. De-
tailed fluorescent embryo imaging of reporter transgenics was
performed by single-plane illumination microscopy (SPIM) with
a Zeiss Lightsheet Z.1 microscope with a plan-apochromat 20×/
1.0 water objective. Prior to imaging, embryos were embedded
in a rod of 1% low-melting agarose in E3 with 0.016% ethyl 3-
aminobenzoate methanesulfonate salt (Tricaine, Sigma) in a 50-
µL glass capillary. Heartbeat was viably stopped with 30 mM
2,3-butanedione monoxime (BDM; Sigma, B0753). Embryos and
their hearts were imaged from opposing sides, and the views
were combined into a single image. Imaging of dissected hearts
was performed with a Leica SP8 confocal microscope using a
plan-apochromat CS2 63×/1.3 glycerol objective.
Image processing was done with Leica LAS, Zeiss Zen Black,
ImageJ/Fiji, and Adobe Photoshop and Illustrator CS6 according
to image-preserving guidelines to ensure unbiased editing of the
acquired image data. Quantitative data analysis was performed
usingGraphpad Prism 5.0. Data are presented asmean±SEM (un-
paired t-test withWelch correction). A lowercase “n” denotes the
number of embryos, while an uppercase “N” signifies the number
of replicates. To perform SPIM on embryonic mouse heart, tissue
samples were extracted at 13.5 dpc, embedded in low-melting
agarose, dehydrated, and cleared using benzyl alcohol/benzyl
benzoate (1:2). Three-dimensional optical sectioning of the anat-
omy of the samples was performed with a Qls-Scope lightsheet
microscopy system (Planelight S.L.) by measuring autofluores-
cence with a 5× objective where the signal was optimal (in this
case, exciting at 532 nm and collecting emission at 590 nm±40
nm). Samples were imaged from two opposing views and com-
bined to form a single volumetric image with an isotropic voxel
size of 2.6 µm.
Mouse lines
Knock-in mutants in Bcl9 and Bcl9l were generated by standard
techniques, as described previously (Cantù et al. 2014). Briefly,
the targeting vector was electroporated into BA1 (C57BL/6×
129/SvEv) hybrid embryonic stem cells. After selection with
the antibiotic G418, surviving clones were expanded for PCR
and Southern blotting analyses to confirm recombinant embry-
onic stem cell clones. Mouse embryonic stem cells harboring
the knock-in allele weremicroinjected intoC57BL/6 blastocysts.
Resulting chimeras were bred to wild-type C57BL/6N mice to
generate F1 heterozygous offspring. Neo cassette excision was
obtained by crossing heterozygous knock-in animals with mice
expressing Flp recombinase. All mouse experiments were per-
formed in accordance with Swiss guidelines and approved by
the Veterinarian Office of the Kanton of Zurich, Switzerland.
Histological analysis
Embryos between 9.5 and 14.5 dpc were fixed overnight in 4%
PFA at 4°C, dehydrated, and embedded in paraffin. Sections
were stained with hematoxylin and eosin for histological analy-
sis. The same paraffin-embedded material was sectioned under
RNase-free conditions for mRNA ISH.
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Mouse whole-mount mRNA ISH
Whole-mount ISH was performed as described previously (Con-
stam and Robertson 2000). The probes for Pax3 and Pitx2 were
kindly provided by Dr. Joerg Huelsken and Dr. Daniel Constam,
respectively. DIG-labeled probes (Roche) were detected by enzy-
matic color reaction using alkaline phosphatase-conjugated
anti-DIG Fab fragments (1:1000; Roche) and BM purple alkaline
phosphatase substrate (Roche). DIG-labeled RNA probes were de-
tected with peroxidase-conjugated anti-DIG Fab fragments
(1:500; Roche) followed by fluorescence detection using Tyra-
mide signal amplification (PerkinElmer). Mouse antisense RNA
probeswere as described in the SupplementalMaterial. Quantita-
tive mRNA ISH for Axin2 was performed using single-molecule
mRNA ISH via RNAscope 2.5 (ACD) according to the manufac-
turer’s instruction. Mean intensity measurements were per-
formed using ImageJ.
Intracardiac injection of India ink
For the analysis of the cardiovascular system, India ink was in-
jected into the left ventricles of mouse embryos at 14.5 dpc using
a finely drawn glass pipette right after embryonic dissection,
when the heart was still beating. The embryos were subsequently
fixed in 4% PFA, and hearts were dissected for the anatomic
examination.
Zebrafish RNA-seq
For zebrafish samples (polyA selection), zebrafish embryos from
bcl9Δ29/wt crosses were dissected at 54 hpf. A cut was made be-
tween the anterior part of the embryo (containing the head, pha-
ryngeal, and cardiac structures) and the posterior part starting
from the beginning of the yolk extension. The anterior tissues
were directly snap-frozen in liquid nitrogen in single tubes of
PCR eight-tube strips. The posterior trunks and tails were trans-
ferred in 50 mM NaOH, and genomic DNA was extracted with
alkaline lysis. Single embryos were genotypes using the target se-
quence primers listed above, and PCR products were separated
through high-percentage gel electrophoresis, leading to a separa-
tion of the wild-type allele and mutant allele with the following
outcome: (1) a low running band in bcl9Δ29 mutants, (2) a high
running band in wild-type, and (3) two bands in bcl9Δ29/wt hetero-
zygousmutants. All snap-frozen anterior parts of bcl9Δ29mutants
and of wild type were pooled in two separate tubes, and RNA iso-
lationwas performedwith theRNeasy Plusminikit (Qiagen). The
whole procedure was repeated for a total of three clutches, mak-
ing three independent replicates.
The TruSeq mRNA stranded kit from Illumina was used for
the library preparation with 250 ng of total RNA as input. The li-
braries were 50 bases sequenced on an Illumina HiSeq 2500
sequencer. The quality control of the resulting reads was done
with FastQC and the reads weremapped to the University of Cal-
ifornia at Santa Cruz (UCSC)Danio rerio danRer10 genome with
the TopHat version 2.0.11 software. For differential expression
analysis, the gene features were counted with HTSeq version
0.6.1 (htseq-count) on the UCSC danRer10 gene annotation.
The normalization and differential expression analyses were per-
formed with R/Bioconductor package EdgeR version 3.14. The P-
values of the differentially expressed genes were corrected for
multiple testing error with a 5% false discovery rate (FDR) using
Benjamini-Hochberg. The volcano plot was done selecting the
genes that have >10 counts per million (CPM) in at least three
samples, P-value < 0.12, and absolute value of log fold change
>1. STRING analysis was performed on differentially expressed
genes implicated in cardiac development in the literature (see
Supplemental Tables S1, S2; permalink to analysis: http://bit.ly/
2wmba7z).
Mouse RNA-seq
Developing heart tubes and adjacent branchial arches 3–6 were
collected from 10.5-dpc mutant and control embryos (N=4).
The Illumina TruSeq stranded total RNA library preparation kit
with RiboZero was used for the library preparation with 300 ng
of total RNA as input. The libraries were 100 bases sequenced
on an Illumina HiSeq 4000 sequencer. The quality control of
the resulting reads was done with FastQC, and the reads were
mapped to theUCSCMusmusculusmm10 genomewith TopHat
version 2.0.11 software. For differential expression analysis, the
gene features were counted with HTSeq version 0.6.1 (htseq-
count) on the UCSC mm10 gene annotation. The normalization
and differential expression analyses were performed with R/Bio-
conductor package EdgeR version 3.14. The P-values of the differ-
entially expressed genes are corrected for multiple testing error
with a 5% FDR using Benjamini-Hochberg.
qRT–PCR
Quantitative real-time SYBR Green-based RT–PCR reactions
were performed in triplicate and monitored with the ABI Prism
7900HT system (Applied Biosystem). Gapdh expression was
used as internal reference. Statistical significance was deter-
mined based on unpaired t-test. Primers sequences are available
on request.
ChIP
Approximately 200 branchial arches of embryonic day 10.5
mouse embryos were dissected and dissociated to a single-cell
suspension. Cells were cross-linked in 20 mL of PBS for 40 min
with the addition of 1.5 mM ethylene glycol-bis(succinimidyl
succinate) (Thermo Scientific) for protein–protein cross-linking
and 1% formaldehyde for the last 20 min of incubation to pre-
serve DNA–protein interactions. The reaction was blocked
with glycine, and the cells were subsequently lysed in 1 mL of
HEPES buffer (0.3% SDS, 1% Triton-X 100, 0.15 M NaCl, 1
mM EDTA, 0.5 mM EGTA, 20 mM HEPES). Chromatin was
sheared using Covaris S2 (Covaris) for 8 min with the following
setup: duty cycle: maximum, intensity: maximum, cycles/burst:
maximum, and mode: power tracking. The sonicated chromatin
was diluted to 0.15% SDS and incubated overnight at 4°C with
anti-IgG (Santa Cruz Biotechnology), anti-PYGO2 (Novus Biolog-
ical, NBP1-46171), and anti-β-catenin (Santa Cruz Biotechnology,
sc-7199). The beads were washed at 4°C with wash buffer 1 (0.1%
SDS, 0.1% deoxycholate, 1% Triton X-100, 0.15 M NaCl, 1 mM
EDTA, 0.5 mMEGTA, 20mMHEPES), wash buffer 2 (0.1% SDS,
0.1%sodiumdeoxycho-late, 1%TritonX-100, 0.5MNaCl, 1mM
EDTA, 0.5mMEGTA, 20mMHEPES), andwash buffer 3 (0.25M
LiCl, 0.5% sodium deoxycholate, 0.5% NP-40, 1 mM EDTA,
0.5 mM EGTA, 20 mM HEPES) and, finally, twice with Tris
EDTA buffer. The chromatin was eluted with 1% SDS and
0.1 M NaHCO3, decross-linked by incubation for 5 h at 65°C
with 200 mM NaCl, extracted with phenol-chloroform, and eth-
anol-precipitated. The immunoprecipitated DNAwas used as in-
putmaterial for DNAdeep sequencing. TheChIP-seq experiment
was performed in duplicate.
Data analysis—peak calling
All sequenced readsweremapped using the tool for fast and sensi-
tive read alignment (Bowtie 2; http://bowtie-bio.sourceforge.net/
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bowtie2/index.shtml) onto the UCSCmm10 referencemouse ge-
nome.The command “findPeaks” from theHOMER tool package
(http://homer.salk.edu/homer) was used to identify enriched re-
gions in the β-catenin immunoprecipitation samples using the
“-style = factor” option (routinely used for transcription factors
with the aim of identifying the precise location of DNA–protein
contact). Input and IgG sampleswere used as enrichment normal-
ization controls. Peak callingparameterswere adjusted as follows:
L= 4 (filtering based on local signal) and F=4 (fold change in target
experiment over input control). Annotation of peak positions (i.e.,
the associationof individual peaks tonearbyannotated genes)was
obtained by the all-in-one program called “annotatePeaks.pl.” Fi-
nally, the HOMER command “makeUCSCfile” was used to pro-
duce bedGraph-formatted files that can be uploaded as custom
tracks and visualized in theUCSC (http://genome.ucsc.edu) or In-
tegrative Genomic Viewer (https://software.broadinstitute.org/
software/igv) genome browsers.
Immunofluorescence
FFPE sections were blocked with 5% heat-inactivated goat se-
rum, 5% BSA, and 0.1% Tween in PBS and incubated overnight
at 4°Cwith the following antibodies: mouse anti p53 5E2 (Novus-
Bio), rabbit anti Sox9 (Millipore), Troponin type2 (NovusBio),
Acta2, and GFP (Aves). Slides were then incubated with a fluores-
cently labeled secondary antibody (Alexa 488 goat anti-mouse,
Alexa 555 goat anti-rabbit, or Alexa 594 goat anti-chicken;
1:500). Nuclei were stained with DAPI (1:1000; Sigma).
Accession codes
ChIP-seq and RNA-seq reads were deposited in the Gene Expres-
sion Omnibus (GEO) repository under the accession codes
GSE108240 for zebrafish mRNA-seq data, GSE110782 for mouse
mRNA-seq data, and GSE110781 for mouse ChIP-seq data.
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